Anima Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 1441.71%
- Profit Growth 7184.39%
- Ebitda -1406.52%
- Net Worth 58.16%
- Total Assets 2.76%
About Anima Pharmaceuticals
Anima Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 May 2012 and has a history of 12 years and nine months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Samiran Sengupta, Pankaj Roy, Anup Dam, and Two other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MH2012PTC230494
- Company No.
230494
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 May 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Anima Pharmaceuticals?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samiran Sengupta  | Director | 01-May-2012 | Current |
Pankaj Roy  | Director | 19-Mar-2019 | Current |
| Anup Dam | Director | 07-Mar-2013 | Current |
| Pradip Chaudhuri | Director | 02-Mar-2015 | Current |
| Ranjana Nagar | Director | 01-Jul-2020 | Current |
Financial Performance of Anima Pharmaceuticals.
Anima Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 1441.71% increase. The company also saw a substantial improvement in profitability, with a 7184.39% increase in profit. The company's net worth Soared by an impressive increase of 58.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anima Pharmaceuticals?
In 2019, Anima Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mesky Online Private LimitedPankaj Roy is a mutual person
Winstratics Services Private LimitedSamiran Sengupta and Pankaj Roy are mutual person
- Pdc Services Private Limited
Samiran Sengupta and Pankaj Roy are mutual person
- Orios Advisors Llp
Pankaj Roy is a mutual person
- Zug Ott Services Private Limited
Pankaj Roy is a mutual person
- Crossover Tank Containers (I) Private Limited
Pankaj Roy is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Anima Pharmaceuticals?
Unlock and access historical data on people associated with Anima Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anima Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anima Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
